Cargando…
Systemic exposure to propranolol in patients with chronic liver disease and its correlation with portal blood flow
Propranolol is a beta-blocker used for the prevention of variceal bleeding in cirrhotic patients. We investigated the pharmacokinetics of propranolol in patients with chronic liver disease compared to that in healthy individuals. The relative amount of portal blood flow was measured to investigate t...
Autores principales: | Kim, Tae-Eun, Kang, Ju-Seop, An, Wen, Sohn, Joo Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533297/ https://www.ncbi.nlm.nih.gov/pubmed/36213672 http://dx.doi.org/10.3389/fmed.2022.973606 |
Ejemplares similares
-
Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
por: Kim, Jae Hyun, et al.
Publicado: (2014) -
Propranolol Reduces Portal Vein Diameter in Schistosomal Liver Disease with Portal Hypertension: A Prospective Cohort Study
por: Sinkala, Edford, et al.
Publicado: (2020) -
Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure
por: Jagdish, Rakesh Kumar, et al.
Publicado: (2023) -
Redistribution of blood flow in experimental hepatic tumours with noradrenaline and propranolol.
por: Burton, M. A., et al.
Publicado: (1987) -
Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure
por: Reboredo, Mercedes, et al.
Publicado: (2013)